Vol. 3 No. 2 (2024): Injuries, Causes, and Treatments, Part 2

The discussion begun in the previous issue of the journal is far from over. Here in Part 2 our call for papers is a continuation of the discussion of injuries and causes, but especially seeking empirical clinical research into successful treatment protocols for any and all aspects of COVID-19 illness as well as the increasingly well-documented sequelae of the experimental injections.

DOI: https://doi.org/10.56098/dfq8ad17

Published: 2024-07-09

Articles

Menstrual Abnormalities Strongly Associated with Proximity to COVID-19 Vaccinated Individuals

Sue E. Peters†, Jill Newman†, Heather Ray, James A. Thorp, Tiffany Parotto, Brian Hooker, Dan McDyer, Leonard Murphy, Raphael B Stricker, Maureen McDonnell, Paul J. Mills, Warren Gieck, Christiane Northrup, †The two lead authors contributed equally.

1435-1461
- PDF
Autoimmune and Neoplastic Outcomes After the mRNA Vaccination: The Role of T Regulatory Cell Responses

Anthony M Kyriakopoulos, Greg Nigh, Peter A McCullough, Stephanie Seneff

1395-1433
- PDF
At Least 55 Undeclared Chemical Elements Found in COVID-19 Vaccines from AstraZeneca, CanSino, Moderna, Pfizer, Sinopharm and Sputnik V, with Precise ICP-MS

Lorena Diblasi, Martín Monteverde, David Nonis, Marcela Sangorrín

1367-1393
- PDF
A Closer Look at N1-methylpseudouridine in the Modified mRNA Injectables

Daniel Santiago

1345-1366
- PDF
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2

M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, Russ Wolfinger, Nicolas Hulscher, Peter A. McCullough

1275-1344
- PDF
Pathology Deterioration in a Pure β-zero Thalassemia Heterozygote After mRNA COVID-19 Vaccination: A Case Report and Literature Review

Anthony M. Kyriakopoulos, Stephanie Seneff

1245-1274
- PDF
Response to Critics of Lee and Broudy 2024 on the Toxicity and Self-Assembling Technology in Incubated Samples of Injectable mRNA Materials

Youngmi Lee; Daniel Broudy

1244.20-1244.29
- PDF
A GMO Experiment on Two-Thirds of the World’s Population: Reaction to Ulrich’s Commentary on Lee and Broudy (2024)

Tamara Tuuminen

1244.11-1244.18
- PDF
No Nanobots in Vaccines — Just Lipids on the Loose: Commentary on Lee and Broudy (2024), “Real-Time Self-Assembly of Stereomicroscopically Visible Artificial Constructs in Incubated Specimens of mRNA Products Mainly from Pfizer and Moderna: A Comprehensive Longitundinal Study”

Anne S. Ulrich

1244.1-1244.10
- PDF
Real-Time Self-Assembly of Stereomicroscopically Visible Artificial Constructions in Incubated Specimens of mRNA Products Mainly from Pfizer and Moderna: A Comprehensive Longitudinal Study

Young Mi Lee, MD, Daniel Broudy, PhD

1180-1244
- PDF
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1

M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, Jessica Rose, Kris Denhaerynck, Steve Kirsch, Peter A McCullough

1112-1178
- PDF
Adverse Outcomes Are Increased with Exposure to Added Combinations of Infant Vaccines

Karl Jablonowski, Brian Hooker

1103-1111
- PDF
Adjuvant Activity and Toxicological Risks of Lipid Nanoparticles Contained in the COVID‑19 “mRNA Vaccines”

Gabriele Segalla

1085-1102
- PDF
Perceived Experience in Social Circles with COVID-19 Injections and COVID-19 “Vaccine” Mandates: An Online Survey of the United States Population

Mark Skidmore, Fernanda Alfaro

1055-1084
- PDF

Vol. 3 No. 2 (2024): Injuries, Causes, and Treatments, Part 2

Articles

Menstrual Abnormalities Strongly Associated with Proximity to COVID-19 Vaccinated Individuals

Autoimmune and Neoplastic Outcomes After the mRNA Vaccination: The Role of T Regulatory Cell Responses

At Least 55 Undeclared Chemical Elements Found in COVID-19 Vaccines from AstraZeneca, CanSino, Moderna, Pfizer, Sinopharm and Sputnik V, with Precise ICP-MS

A Closer Look at N1-methylpseudouridine in the Modified mRNA Injectables

COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2

Pathology Deterioration in a Pure β-zero Thalassemia Heterozygote After mRNA COVID-19 Vaccination: A Case Report and Literature Review

Response to Critics of Lee and Broudy 2024 on the Toxicity and Self-Assembling Technology in Incubated Samples of Injectable mRNA Materials

A GMO Experiment on Two-Thirds of the World’s Population: Reaction to Ulrich’s Commentary on Lee and Broudy (2024)

No Nanobots in Vaccines — Just Lipids on the Loose: Commentary on Lee and Broudy (2024), “Real-Time Self-Assembly of Stereomicroscopically Visible Artificial Constructs in Incubated Specimens of mRNA Products Mainly from Pfizer and Moderna: A Comprehensive Longitundinal Study”

Real-Time Self-Assembly of Stereomicroscopically Visible Artificial Constructions in Incubated Specimens of mRNA Products Mainly from Pfizer and Moderna: A Comprehensive Longitudinal Study

COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1

Adverse Outcomes Are Increased with Exposure to Added Combinations of Infant Vaccines

Adjuvant Activity and Toxicological Risks of Lipid Nanoparticles Contained in the COVID‑19 “mRNA Vaccines”

Perceived Experience in Social Circles with COVID-19 Injections and COVID-19 “Vaccine” Mandates: An Online Survey of the United States Population

Information

Language